Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06038630 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

129Xe MRI Cardiopulmonary

StatusRecruiting
PhasePhase 2
Started2024-01-12
View on ClinicalTrials.gov ↗

Amendment history

2026-02-02
minor
2 amendments v5-v6
2 re-verifications since 2025-02-25, no change to tracked fields
2024-02-19
minor
Study Status, Study Description, Conditions, Arms and Interventions, Outcome Measures, Eligibility v4
Eligibility criteria+66 characters
[...] to visit/protocol And one of the following categories (ILD, Dyspnea, CTEPH, or Healthy): Interstitial Lung Disease or Dyspnea Physician diagnosis of Interstitial Lung Disease by a pulmonologist using established criteria or physician referral of patient with dyspnea OR Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Pa [...]
Study description+20 characters
[...] tients scheduled to undergo either transfusion or phlebotomy, those with dyspnea, those with a physician diagnosis of interstitial lung dise [...]
2024-01-16
notable
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-01→confirmed 2024-01-12
Study sitesdetails revised at 1 of 1 site
2023-12-14
minor
Study Status v2
Start date2023-11→2024-01
2023-10-24
minor
Study Status v1
Start date2023-09-25→2023-11
2023-09-08
minor
Original filing
The goal of this NIH-sponsored study is to characterize three biomarkers derived from 129Xe gas exchange MRI and to understand how they change in response to interventions.
Trial Details
NCT Number NCT06038630
Lead Sponsor Bastiaan Driehuys
Collaborators: National Institutes of Health (NIH)
Conditions Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism, Anemia, Polycythemia, Dyspnea
Enrollment 125 participants
Start Date 2024-01-12
Primary Completion 2028-06-30 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-04